Paul Tappenden

Best Publications

• Chemoprevention of colorectal cancer: systematic review and economic evaluation

  K Cooper;H Squires;C Carroll;D Papaioannou

  296
  Citations

• A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negative

  J Chilcott;M Lloyd Jones;J Wight;K Forman

  283
  Citations

• A systematic review and economic evaluation of exercise referral schemes in primary care: a short report.

  Fiona Campbell;Mike Holmes;Emma Everson-Hock;Sarah Davis

  245
  Citations

• A review of the natural history and epidemiology of multiple sclerosis: implications for resource allocation and health economic models.

  RG Richards;FC Sampson;Stephen Beard;P Tappenden

  221
  Citations

• Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis

  Jim Chilcott;Chris Mccabe;Paul Tappenden;Anthony O'hagan

  195
  Citations

• Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer

  P Tappenden;R Jones;S Paisley;C Carroll

  192
  Citations

• Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation

  Paul Tappenden;R. Jackson;K. Cooper;A. Rees

  180
  Citations

• A review and critique of modelling in prioritising and designing screening programmes.

  J. Karnon;E. Goyder;P. Tappenden;S. McPhie

  178
  Citations

• Option appraisal of population-based colorectal cancer screening programmes in England

  Paul Tappenden;James Bromley Chilcott;Simon Eggington;Julietta Patnick

  171
  Citations

• The Clinical Effectiveness and Cost-Effectiveness of Home-Based, Nurse-Led Health Promotion for Older People: A Systematic Review

  P Tappenden;F Campbell;A Rawdin;R Wong

  159
  Citations

• Distributional cost-effectiveness analysis of health care programmes--a methodological case study of the UK Bowel Cancer Screening Programme.

  Miqdad Asaria;Susan Griffin;Richard Cookson;Sophie Whyte

  148
  Citations

• The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation

  D Hind;P Tappenden;I Tumur;S Eggington

  142
  Citations

• Methodological issues in the economic analysis of cancer treatments.

  Paul Tappenden;Jim Chilcott;Sue Ward;Simon Eggington

  133
  Citations

• The role of modelling in prioritising and planning clinical trials.

  Jim Chilcott;Alan Brennan;Andrew Booth;Jonathan Karnon

  130
  Citations

• Methods for expected value of information analysis in complex health economic models: developments on the health economics of interferon-β and glatiramer acetate for multiple sclerosis

  P Tappenden;J B Chilcott;S Eggington;J Oakley

  127
  Citations

• The cost-effectiveness of bevacizumab in the first-line treatment of metastatic colorectal cancer in England and Wales

  P. Tappenden;R. Jones;S. Paisley;C. Carroll

  113
  Citations

• Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy

  Linda Sharp;Lesley Tilson;Sophie Whyte;Alan O'Ceilleachair

  109
  Citations

• The clinical effectiveness and cost-effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy (review of technology appraisal No. 150 and part review of technology appraisal No. 118): a systematic review and economic model

  Martin Hoyle;Louise Crathorne;Jaime Peters;Tracey Jones-Hughes

  106
  Citations

• Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review

  J Chilcott;P Tappenden;A Rawdin;M Johnson

  104
  Citations

• The Multiple Sclerosis Risk Sharing Scheme Monitoring Study – early results and lessons for the future

  Mark Pickin;Cindy L Cooper;Timothy Chater;Anthony O'Hagan

  93
  Citations